HEALTH

USA Today: Two products masquerading as supplements contain methamphetamine-like substance

BY Michael Johnsen

WASHINGTON — USA Today on Monday morning reported two products marketed as dietary supplements in outlets including Walmart.com and GNC have actually been adulterated with a chemical similar to methamphetamine.  

The supplements included Craze, a pre-workout powder sold by Driven Sports, and Gaspari Nutrition’s weight loss supplement Detonate. 

"These are basically brand-new drugs that are being designed in clandestine laboratories where there’s absolutely no guarantee of quality control," Pieter Cohen, an assistant professor at Harvard Medical School and a co-author of the analysis of Craze samples that’s being published Monday in the peer-reviewed scientific journal Drug Testing and Analysis, told USA Today

USA Today reported that Walmart.com and several online retailers had stopped selling Craze in the wake of USA Today‘s initial investigation into the supplements. Detonate is sold by a variety of online retailers, the paper reported.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Sanofi: Nasacort first nasal corticosteroid available without a prescription

BY Michael Johnsen

PARIS — Allergy sufferers will have a new treatment option available to them by the spring allergy season. Sanofi on Friday announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. 

Nasacort is the first and only nasal corticosteroid to be available without a prescription and will be marketed by Sanofi’s consumer healthcare division, Chattem.

This makes Chattem the new allergy powerhouse. The company already fields Allegra, and for the 52 weeks ended July 14, Allegra products generated more than $335 million in revenue across total U.S. multi-outlets, according to IRI. 

"[Chattem’s] Allegra is already neck-and-neck with Claritin," noted Laura Mahecha, industry manager at Kline Healthcare. But the nasal format is not expected to become as big as the competing allergy tablets, including Allegra, she said, because tablets are perceived to be a preferred delivery form among consumers. 

That would cap Nasacort’s potential at around $200 million. "[But] each person’s allergies are different," she said. "There may be a whole group of people [whose allergies respond] better to the nasal steroids."

Together with Allegra, Chattem’s OTC allergy portfolio would approach $450 million in annual sales if sales of Nasacort reached even $100 million in sales. 

Nasacort is the only single active ingredient OTC medicine that relieves the full range of nasal allergy symptoms, including nasal congestion, for 24 hours with a single daily dose, Sanofi asserted. 

Chattem anticipates that Nasacort will be available in spring 2014.

 

 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Neat Feat launches Baby B Diaper Cream

BY Michael Johnsen

LOS ANGELES — Neat Feat Baby B Diaper Cream is a preventive cream that helps treat the cause of the rash and restores the normal environment of the skin, according to the company. 

The product also inhibits growth of fungi that contributes to skin irritation and reduces excess moisture, promoting a more natural Ph balance for the skin, the company stated.

BabyB Baby Saver Cream is part of Neat Feat’s new Body Saver range. 

The product is available nationally through Walgreens stores at a suggested retail price of $6.95.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?